Related Experiment Video

Updated: Jun 12, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.2K

Strategies to improve autoimmune neurological diseases treatment

F Leypoldt1

  • 1Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel and Lübeck, Germany; Department of Neurology, University Hospital Schleswig-Holstein, Kiel, Germany.

Revue Neurologique
|September 19, 2024
PubMed

Insights

Developing better therapies for autoimmune neurologic conditions requires identifying molecular targets and addressing the "evidence-bottleneck". This review outlines strategic objectives and therapeutic options for neuroimmunology.

Area of Science:

  • Neuroimmunology
  • Autoimmune Neurologic Conditions

Background:

  • Current therapies for autoimmune neurologic conditions require improvement.
  • Key challenges include identifying molecular targets and subgrouping patients.

Purpose of the Study:

  • To summarize strategic objectives for advancing neuroimmunology therapies.
  • To identify barriers and discuss potential solutions for autoimmune neurologic conditions.

Main Methods:

  • Literature review and synthesis of current research in neuroimmunology.
  • Discussion of therapeutic strategies, including target identification and B- and T-cell roles.

Main Results:

  • Challenges include target identification, biomarker-defined subgroups, and the "evidence-bottleneck".
  • Therapeutic strategies should focus on autoreactivity-specificity over cell-type specificity.
  • B- and T-cells offer therapeutic targets in autoimmune neurology.

Conclusions:

  • Improved training for neuroimmunologists is crucial.
  • Advancing therapies necessitates addressing strategic objectives and overcoming identified barriers.
Keywords:
Autoimmune encephalitisMolecular therapiesMyasthenia gravisNeuromyelitis opticaTargeted therapyVasculitis

More Related Videos

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis06:19

Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis

Published on: September 9, 2022

3.5K
Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research05:55

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research

Published on: December 1, 2023

775

Related Concept Videos

Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
395
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
145
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
118
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
170